Druggable Targets of Squamous Cell Lung Cancer.
10.4046/trd.2013.75.6.231
- Author:
Cheol Hyeon KIM
1
Author Information
1. Division of Pulmonology, Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea. cheol@kcch.re.kr
- Publication Type:Review
- Keywords:
Carcinoma, Squamous Cell;
Lung Neoplasms
- MeSH:
Adenocarcinoma;
Carcinoma, Non-Small-Cell Lung;
Carcinoma, Squamous Cell;
Lung Neoplasms*;
Lung*
- From:Tuberculosis and Respiratory Diseases
2013;75(6):231-235
- CountryRepublic of Korea
- Language:English
-
Abstract:
Knowledge of molecular pathogenesis of non-small cell lung cancer has increased remarkably and changed the principles of treatment, especially during the past decade. These advancements have been limited mainly to adenocarcinoma of the lung. Recently, genetic alterations in squamous cell lung cancer (SQCLC) have been detailed and positive results of clinical trials using agents targeting these changes have indicated the potential for improved treatment outcomes for SQCLC.
